LINC02276: A Long Intergenic Non-Protein Coding RNA (G105377456)

Target Name: LINC02276

NCBI ID: G105377456

LINC02276

Other Name(s): long intergenic non-protein coding RNA 2276 | Long intergenic non-protein coding RNA 2276, transcript variant X1 | LINC02276 variant X1

LINC02276: A Long Intergenic Non-Protein Coding RNA

Introduction

LINC02276 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its unique 2276 base length and its non-protein coding nature. LncRNAs, as the name suggests, are not proteins but instead RNA molecules that have important functions in gene regulation and cell biology.

The discovery and characterization of LINC02276 has important implications for our understanding of the complexity of gene expression and the mechanisms underlying non-coding RNA (ncRNA) regulation. LncRNAs have been shown to play critical roles in the regulation of gene expression, stem cell maintenance, and tissue homeostasis. As such, LINC02276 is a potential drug target or biomarker that can be targeted to modulate cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Structure and Function

The structure of LINC02276 is highly conserved across different organisms, which indicates that it has a conserved core sequence. It has a unique 5'-end that is specific to LINC02276 and is followed by a variable 3'-end. The 5'-end contains a putative RNA binding protein (RBP) consensus sequence that is known to interact with RNA binding proteins, which are important for the regulation of gene expression.

The 3'-end of LINC02276 contains a unique stem-loop structure that is specific to this RNA. The stem-loop is a common motif that is found in many ncRNAs and is responsible for the stability and translation of the RNA into protein. unique stem-loop design of LINC02276 may have implications for its stability and function.

Expression and Regulation

LINC02276 is highly expressed in various tissues and organs, including brain, heart, and muscle. It has been shown to play important roles in the regulation of cellular processes, including cell adhesion, migration, and invasion. LINC02276 has also been shown to be involved. in the regulation of stem cell proliferation and differentiation.

The expression of LINC02276 is regulated by various factors, including post-transcriptional modifications (RNA binding proteins, miRNA, RNA interference) technology, etc. These regulations are important for the stability and function of LINC02276 and its role in cellular processes.

Drug Targeting

The unique properties of LINC02276 make it an attractive drug target. The conserved 5'-end and the specific stem-loop structure make it a likely candidate for small molecules that can interact with the RNA-binding protein (RBP) consensus sequence. Additionally, the 3'-end unique to LINC02276 may make it more susceptible to RNA interference (RNA interference) technology.

In conclusion

LINC02276 is a long intergenic non-protein coding RNA that has unique properties and functions. Its conserved core sequence, the stem-loop structure, and the 5'-end that are specific to LINC02276 make it a potential drug target or biomarker. Further research is needed to fully understand the role of LINC02276 in cellular processes and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 2276

The "LINC02276 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02276 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets